000 | 03307nam a22004337a 4500 | ||
---|---|---|---|
001 | MT 2023 0009 | ||
003 | PILC | ||
005 | 20241031083133.0 | ||
008 | 230526b xxu||||| |||| 00| 0 eng d | ||
040 |
_beng _cFEU-NRMF MEDICAL LIBRARY _erda |
||
041 | _aenglish | ||
050 | _aMT 2023 0009 | ||
245 |
_aA Systematic review of laboratory parameters predictive of long haul COVID-19 / _cAliyah B. Aurellana, Camille Serg R. De Guzman, Tom Cedrick G. Estrella, Cara Angela S. Nayve, Miryltrix A. Pedroche, Angela Mae S. Sarangaya, Erica Mae F. Shabado, Jan Naomi C. Tomes, John Robert A. Villalon, Angel Mikaela S. Villarama, Jane Louise S. Villareal and Ma. Kathlene Angela V. Villostas. |
||
260 |
_aFairview, Quezon City: _bSchool of Medical Technology, FEU-NRMF, _c2023. |
||
300 |
_a55 pages: _billustrations, tables; _c28 cm. |
||
336 |
_2rdacontent _atext |
||
337 |
_2rdamedia _aunmedaited |
||
338 |
_2rdacarrier _avolume |
||
504 | _aIncludes appendices and bibliographical references. | ||
520 | _aAbstract: The aftermath of COVID-19 infection resulted in a syndrome now called long-haul COVID-19. It is a condition wherein the clinical signs and symptoms persist for an extended period. Persistent symptoms manifested by patients are fatigue, cough, dyspnea, headache, brain fog, anosmia, and dysgeusia. But, symptoms experienced by patients may vary, thus making diagnosing the syndrome complex. A total of 14 studies published between 2020 to 2022 gathered from ScienceDirect, ResearchGate and PubMed were included in the systematic review. The researchers utilized PRISMA guidelines to systematically review all possible laboratory parameters used to predict long-haul COVID-19. Results showed that C-reactive Protein, D-dimer, Erythrocyte Sedimentation Rate, Interleukin-2, Interleukin-6, Lymphocyte, Total Antibodies, Troponin-I, Interferon-β, Interferon-λ1 and Ferritin are associated with the development and persistence of symptoms manifested by long-haul patients and can be used as the parameter for diagnosis. Meanwhile, Lactate dehydrogenase (LDH), Alanine transaminase (ALT), Aspartate aminotransferase (AST), Total Bilirubin, Creatinine, Lipocalin-2, Matrix Metalloproteinases-7, and Hepatocyte growth factor showed probable association with long-haul COVID-19. However, it still requires further validation on extensive studies before it can be used as a parameter for the long haul. | ||
521 | _aTHMT | ||
650 | _aCOVID-19 | ||
650 | _along-haul COVID-19 | ||
650 | _alaboratory parameters | ||
700 |
_aAurellana, Aliyah B. _eauthor |
||
700 |
_aDe Guzman, Camille Serg R. _eauthor |
||
700 |
_aEstrella, Tom Cedrick G. _eauthor |
||
700 |
_aNayve, Cara Angela S. _eauthor |
||
700 |
_aPedroche, Miryltrix A. _eauthor |
||
700 |
_aSarangaya, Angela Mae S. _eauthor |
||
700 |
_aShabado, Erica Mae F. _eauthor |
||
700 |
_aTomes, Jan Naomi C. _eauthor |
||
700 |
_aVillalon, John Robert A. _eauthor |
||
700 |
_aVillarama, Angel Mikaela S. _eauthor |
||
700 |
_aVillareal, Jane Louise S. _eauthor |
||
700 |
_aVillostas, Ma. Kathlene Angela V. _eauthor |
||
856 |
_21 _30 _qpdf _uhttps://library.feu-nrmf.ph/cgi-bin/koha/opac-retrieve-file.pl?id=512b4da8bf5c5f76fa6b28e44dd9abcc _yClick here for FULL TEXT _1ALL |
||
942 |
_2lcc _cRU |
||
999 |
_c12534 _d12534 |